Welcome!

News Feed Item

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

LONDON, Jan. 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management coupled with increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. On the other hand, high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, cell surface makers study has undergone tremendous technological development, and it is expected that soon end-users will be benefited from the increasing scope of applications of cell surface markers.

This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year.

In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied.

The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Some of the key market players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc. and Janssen Diagnostics, Inc.

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
3.2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
3.3 Drivers
3.3.1 Growing Automation in Laboratories
3.3.2 Discovery of New Markers will Need New Antibodies
3.3.3 Increased Use of In Vitro Diagnostics
3.3.4 Need for Lowering Healthcare Expenditure
3.4 Restraints
3.4.1 Reluctance for High Investment in Sophisticated Models
3.4.2 Complexity in the Use of Flow Cytometers
3.5 Opportunities
3.5.1 Growth in Expertise for Operation of Cell Marking Tools
3.5.2 Targeted Therapy and Personalized Medicine
3.6 Porter's Five Force Analysis for the Global Cell Surface Markers Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis of Global Cell Surface Markers Market, by Instruments and Reagents, 2012

Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
4.2 Flow Cytometry
4.2.1 Global Flow Cytometers Market Revenues, 2013 – 2019 (USD Million)
4.2.2 Global Flow Cytometers Market Volume, 2013 – 2019 (Number of Units Installed)
4.3 Hematology Analyzers
4.3.1 Global Hematology Analyzers Market Revenues, 2011 – 2019 (USD Million)
4.3.2 Global Hematology Analyzers Market Volume, 2013 – 2019 (Number of Units Installed)
4.4 Reagents and Kits
4.4.1 Global Reagent and Kits Market Revenues, 2011 – 2019 (USD Million)

Chapter 5 Global Cell Surface Markers Market, by Applications
5.1 Disease Diagnosis
5.1.1 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 – 2019 (USD Million)
5.2 Research and Drug Discovery
5.2.1 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 – 2019 (USD Million)

Chapter 6 Global Cell Surface Markers Market, by Geography
6.1 Introduction
6.2 North America
6.2.1 North America Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Strategic Overview
8.1.3 Financial Overview
8.1.4 Product Portfolio
8.1.5 Recent Developments
8.2 Beckman Coulter, Inc.
8.2.1 Company Overview
8.2.2 Strategic Overview
8.2.3 Financial Overview
8.2.4 Product Portfolio
8.2.5 Recent Developments
8.3 BD Biosciences
8.3.1 Company Overview
8.3.2 Strategic Overview
8.3.3 Financial Overview
8.3.4 Product Portfolio
8.3.5 Recent Development
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Strategic Overview
8.4.3 Financial Overview
8.4.4 Product Portfolio
8.4.5 Recent Development
8.5 Grifols SA
8.5.1 Company Overview
8.5.2 Strategic Overview
8.5.3 Financial Overview
8.5.4 Product Portfolio
8.5.5 Recent Development
8.6 Immucor, Inc.
8.6.1 Company Overview
8.6.2 Strategic Overview
8.6.3 Financial Overview
8.6.4 Product Portfolio
8.6.5 Recent Developments
8.7 Janssen Diagnostics, Inc.
8.7.1 Company Overview
8.7.2 Strategic Overview
8.7.3 Financial Overview
8.7.4 Product Portfolio
8.7.5 Recent development
8.8 Nihon Kohden Corporation
8.8.1 Company Overview
8.8.2 Strategic Overview
8.8.3 Financial Overview
8.8.4 Product Portfolio
8.8.5 Recent developments
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Strategic Overview
8.9.3 Financial Overview
8.9.4 Product Portfolio
8.9.5 Recent Developments
8.10 Siemens Healthcare
8.10.1 Company Overview
8.10.2 Strategic Overview
8.10.3 Financial Overview
8.10.4 Product Portfolio
8.10.5 Recent Developments
8.11 Sysmex Corporation
8.11.1 Company Overview
8.11.2 Strategic Overview
8.11.3 Financial Overview
8.11.4 Product Portfolio
8.11.5 Recent Development
8.12 Thermo Fischer Scientific, Inc.
8.12.1 Company Overview
8.12.2 Strategic Overview
8.12.3 Financial Overview
8.12.4 Product Portfolio
8.12.5 Recent Development

LIST OF FIGURES

FIG. 1 Cell Surface Markers: Market Segmentation
FIG. 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2012 (USD Million)
FIG. 3 Global Cell Surface Markers Market Revenues, by Geography, 2012 (USD Million)
FIG. 4 Porter's Five Force Analysis: Global Cell Surface Markers Market
FIG. 5 Market Attractive Analysis: Global Cell Surface Markers Market, by Instruments and Reagents, 2012
FIG. 6 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
FIG. 7 Global Flow Cytometers Market Revenues, 2011 - 2019 (USD Million)
FIG. 8 Global Flow Cytometers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 9 Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
FIG. 10 Global Hematology Analyzers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 11 Global Reagents and Kits Market Revenues, 2011 - 2019 (USD Million)
FIG. 12 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
FIG. 13 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)
FIG. 14 North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 15 Europe Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 16 Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019(USD Million)
FIG. 17 Rest of the World (RoW) Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 18 Annual Revenues of Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenues of Bio-Rad Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenues of Grifols SA, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenues of Immucor, Inc., 2010 – 2012 (USD Million)
FIG. 22 Annual Revenues of Nihon Kohden Corp., 2010 – 2012 (USD Million)
FIG. 23 Annual Revenues of Hoffmann-La Roche Ltd., 2010 – 2012 (USD Million)
FIG. 24 Annual Revenues of Siemens Healthcare, 2010 – 2012 (USD Million)
+FIG. 25 Annual Revenues of Sysmex Corporation, 2010 – 2012 (USD Million)
FIG. 26 Annual Revenues of Thermo Fischer Scientific, Inc., 2010 – 2012 (USD Million)

LIST OF TABLES

TABLE 1 Market Snapshot: Global Cell Surface Markers Market
TABLE 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 3 Global Cell Surface Markers Market Revenues, by Geography, Size and Forecast, 2013-2019 (USD Million)
TABLE 4 North America Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 5 Europe Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 6 Asia-Pacific Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 7 RoW Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)

Read the full report:
Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
http://www.reportbuyer.com/pharma_healthcare/diagnostics/cell_surface_markers_flow_cytometers_hematology_analyzers_reagents_kits_market_global_industry_analysis_size_share_growth_trends_forecast_2012_2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DX World EXPO, LLC, a Lighthouse Point, Florida-based startup trade show producer and the creator of "DXWorldEXPO® - Digital Transformation Conference & Expo" has announced its executive management team. The team is headed by Levent Selamoglu, who has been named CEO. "Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation," he said in making the announcement.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Conference Guru has been named “Media Sponsor” of the 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. A valuable conference experience generates new contacts, sales leads, potential strategic partners and potential investors; helps gather competitive intelligence and even provides inspiration for new products and services. Conference Guru works with conference organizers to pass great deals to gre...
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develop...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
"ZeroStack is a startup in Silicon Valley. We're solving a very interesting problem around bringing public cloud convenience with private cloud control for enterprises and mid-size companies," explained Kamesh Pemmaraju, VP of Product Management at ZeroStack, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Large industrial manufacturing organizations are adopting the agile principles of cloud software companies. The industrial manufacturing development process has not scaled over time. Now that design CAD teams are geographically distributed, centralizing their work is key. With large multi-gigabyte projects, outdated tools have stifled industrial team agility, time-to-market milestones, and impacted P&L stakeholders.
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...